Several therapeutic advances have been achieved over the past two decades for inflammatory bowel disease (IBD). The expanding ...

Since the first, seminal randomised controlled trial (RCT) in inflammatory bowel disease (IBD) in 1955,1 the central tenets for high-quality clinical trials have been recognised as robust and ...

As India awaits Union Budget 2025, key expectations in education include GST reduction, bridging the skill gap, boosting ...

In addition to its close-range Taser energy weapons, Axon makes body and fleet cameras, along with drones and evidence ...

Colorectal cancer is becoming a significant public health issue in India, especially among individuals under 50 years old.

Brian Kirwan was one of Carlow's best athletes but behind the scenes he was battling a gambling addiction that made him lose ...

Stock Of The Day: S&P 500 component TJX advanced toward an early buy point Tuesday, after testing its 50-day line Monday.

Square parent Block is the IBD Stock of the Day as the digital payments company climbs above its 50-day moving average, forging an early entry point.

The HUMANOID Center at UC San Diego is pioneering organoid research aimed at improving the reliability and reproducibility of ...

Armed with positive data from a phase 2b trial, Teva and Sanofi have decided to push their anti-TL1A antibody duvakitug into a phase 3 programme in inflammatory bowel disease (IBD). The results of ...

Celebrity nutritionist Rujuta Diwekar shares expert insights on reducing inflammation naturally through balanced nutrition ...